Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and
commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct
cancer care, stem cell therapy and unique prescription products.
Read more